Latest Healthcare Research Reports

Tag: minimally invasive surgery

  • Lumbosacral Radicular Pain Management Industry Growth Expected to Reach $1.11 Billion by 2029 at a CAGR of 5.5% | Segmentation and Growth Opportunities

    Lumbosacral Radicular Pain Management Industry Growth Expected to Reach $1.11 Billion by 2029 at a CAGR of 5.5% | Segmentation and Growth Opportunities

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    #What Is the Forecast for the Lumbosacral Radicular Pain Management Market Growth in 2025?#_x000D_

    Recent years have seen substantial growth in the lumbosacral radicular pain management market, with projections showing it expanding from a value of $0.85 billion in 2024 to $0.9 billion in 2025, a compound annual growth rate (CAGR) of 5.8%. The significant growth experienced in the historical period can be traced back to several contributing factors, including a heightened prevalence of lumbar disc herniation, increased consciousness about spinal disorders, a growing number of elderly, advancements in diagnostic imaging technology, and the growing inclination towards non-invasive pain management treatments._x000D_

    _x000D_

    #What Is the Forecast for the Lumbosacral Radicular Pain Management Market Size Through 2029?#_x000D_

    The market size for managing lumbosacral radicular pain is anticipated to undergo substantial growth in the upcoming years, with projections indicating expansion to $1.11 billion by 2029, experiencing a compound annual growth rate (CAGR) of 5.5%. Factors contributing to this growth during the forecast period include the introduction of innovative minimally invasive surgical methods, increased usage of biologic therapies, a heightened emphasis on individualized pain management, more demand for outpatient pain clinics, and the incorporation of digital health and telemedicine into pain control strategies. Also, notable trends expected over the forecast period are advancements in minimally invasive procedures for the spine, improvements in neurostimulation devices, adoption of biologic therapies such as platelet-rich plasma, AI-enabled diagnostics and tailored treatment agendas, and the emergence of new non-opioid analgesics._x000D_

    _x000D_

    #Download The Free Sample Report Here:#_x000D_

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24592&type=smp_x000D_

    _x000D_

    #What are the Key Market Players in Lumbosacral Radicular Pain Management Market and How They’re Evolving?#_x000D_

    Major companies operating in the lumbosacral radicular pain management market are Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb, AstraZeneca plc, Novartis AG, GSK plc, Medtronic plc, Eli Lilly and Company, Amgen Inc, Koninklijke Philips NV, Stryker Corporation, Teva Pharmaceutical Industries Ltd, Boston Scientific Corporation, Dr Reddy’s Laboratories Ltd, NuVasive Inc., Nobel Biocare Holdings AG, Ultradent Products Inc., Nevro Corp., Zynex Inc., Eliem Therapeutics, Vertebral Technologies Inc., Semnur Pharmaceuticals Inc._x000D_

    _x000D_

    #What Are the Primary Growth Drivers in the Lumbosacral Radicular Pain Management Market?#_x000D_

    The escalating occurrence of back pain ailments is anticipated to steer the expansion of the lumbosacral radicular pain management market in the future. Back pain ailments encompass several conditions impacting the spine, muscles, or nerves in the back, leading to discomfort or pain. The escalating occurrence can be ascribed to sedentary lifestyles that lead to weakness in the back muscles, resulting in poor posture and ongoing pain. The goal of lumbosacral radicular pain management is to alleviate nerve root irritation in the lower back, decreasing pain and inflammation. This enhances mobility and life quality. For instance, data from the Australian Institute of Health and Welfare, a government agency based in Australia, reveals that in June 2024, over 52% of all hospitalizations for back issues in 2022 were ascribed to back or spine pain. Lower back pain was responsible for the most significant portion at 27%, succeeded by neck pain at 6.2% and radiculopathy at 6.0%. Furthermore, back issues had escalated to the third leading factor contributing to the overall health burden, representing 4.3% of the total in 2023. Thus, the escalating occurrence of back pain ailments stimulates the expansion of the lumbosacral radicular pain management market._x000D_

    _x000D_

    #Request For A Customized Report:#_x000D_

    https://www.thebusinessresearchcompany.com/customise?id=24592&type=smp_x000D_

    _x000D_

    #What Are the Leading Segments in the Global Lumbosacral Radicular Pain Management Industry?#_x000D_

    The lumbosacral radicular pain management market covered in this report is segmented –_x000D_

    _x000D_

    1) By Medication: Non-Steroidal Anti-Inflammatory Drugs, Opioids, Antidepressants, Anticonvulsants, Steroids_x000D_

    2) By Physical Therapy: Manual Therapy, Exercise Therapy, Electrotherapy, Thermal Therapy, Hydrotherapy_x000D_

    3) By Route Of Administration: Oral, Topical_x000D_

    4) By End-User: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy_x000D_

    _x000D_

    Subsegments:_x000D_

    1) By Non-Steroidal Anti-Inflammatory Drugs: Ibuprofen, Naproxen, Diclofenac, Celecoxib, Etoricoxib_x000D_

    2) By Opioids: Tramadol, Oxycodone, Morphine, Hydrocodone, Fentanyl_x000D_

    3) By Antidepressants: Amitriptyline, Nortriptyline, Duloxetine, Desvenlafaxine, Venlafaxine_x000D_

    4) By Anticonvulsants: Gabapentin, Pregabalin, Carbamazepine, Lamotrigine, Topiramate_x000D_

    5) By Steroids: Dexamethasone, Methylprednisolone, Prednisone, Triamcinolone, Hydrocortison_x000D_

    _x000D_

    #What Are the Key Market Trends in the Lumbosacral Radicular Pain Management Industry?#_x000D_

    Leading organizations in the lumbosacral radicular pain management market are shifting their attention towards the creation of advanced therapeutic options. This includes experimental oral NaV1.8 pain signal inhibitors which act as a non-opioid substitute for enduring pain relief. This investigational oral NaV1.8 pain signal inhibitor is a medication under trial that zeroes in on the NaV1.8 sodium channel, an essential route for the transmission of pain via sensory nerves. For instance, Vertex Pharmaceuticals, a biotech firm based in the US, revealed the outcomes from its Phase 2 study on suzetrigine intended for painful lumbosacral radiculopathy (LSR) in December 2024. The study fulfilled its main goal, exhibiting a statistically significant and clinically relevant decline in pain from the baseline in the suzetrigine group. Suzetrigine was generally well received, with no severe adverse events reported. Vertex intends to tackle the high placebo response in subsequent Phase 3 trials so as to better evaluate the drug’s effectiveness._x000D_

    _x000D_

    #Access The Full Report Here:#_x000D_

    https://www.thebusinessresearchcompany.com/report/lumbosacral-radicular-pain-management-global-market-report_x000D_

    _x000D_

    #What Is the Regional Outlook for the Lumbosacral Radicular Pain Management Market?#_x000D_

    North America was the largest region in the lumbosacral radicular pain management market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lumbosacral radicular pain management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

    _x000D_

    #Purchase The Full Report Today:#_x000D_

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24592_x000D_

    _x000D_

    #This Report Delivers Insight On: #_x000D_

    1. How big is the lumbosacral radicular pain management market, and how is it changing globally?_x000D_

    2. Who are the major companies in the lumbosacral radicular pain management market, and how are they performing?_x000D_

    3. What are the key opportunities and risks in the lumbosacral radicular pain management market right now?_x000D_

    4. Which products or customer segments are growing the most in the lumbosacral radicular pain management market?_x000D_

    5. What factors are helping or slowing down the growth of the lumbosacral radicular pain management market?_x000D_

    _x000D_

    #About The Business Research Company:#_x000D_

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

    _x000D_

    #Get in touch with us:#_x000D_

    The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

    Americas +1 3156230293_x000D_

    Asia +44 2071930708_x000D_

    Europe +44 2071930708_x000D_

    Email us at info@tbrc.info_x000D_

    _x000D_

    #Follow us on:#_x000D_

    _x000D_

    LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Lateral Epicondylitis Treatment Forecast Report – Designed for Decision Makers and Product Teams

    Lateral Epicondylitis Treatment Forecast Report – Designed for Decision Makers and Product Teams

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    #What Is the Growth Rate of the Lateral Epicondylitis Treatment Market?#_x000D_

    The market for treating lateral epicondylitis has experienced a robust growth in the last few years. Expanding from $2.22 billion in 2024, it is projected to reach $2.34 billion in 2025, a compound annual growth rate (CAGR) of 5.4%. This surge during the historical period can be due to several factors such as increasing instances of lateral epicondylitis, an older population susceptible to musculoskeletal conditions, higher occurrence in athletes and people doing manual work, raising awareness of repetitive strain injuries, along with the urban lifestyle leading to joint or muscle strain._x000D_

    _x000D_

    #What Growth Rate Is Forecasted for the Lateral Epicondylitis Treatment Market by 2029?#_x000D_

    The market size for the treatment of lateral epicondylitis is anticipated to experience significant expansion in the coming years, reaching approximately $2.84 billion in 2029, an increase characterized by a compound annual growth rate (CAGR) of 5.0%. This anticipated growth during the forecast period can be linked to various factors including an increase in people playing tennis and racquet sports, an uptick in workplace dangers in construction and manufacturing industries, higher disposable income leading to greater accessibility to treatments, a broader network of physical therapy and orthopedic clinics, and the growing influence of sports medicine departments. Noteworthy trends expected in the forecast period are the innovation in non-invasive treatment methods, the rise of regenerative medicine, advancements in robotic-assisted physiotherapy, the increasing market for wearable rehabilitation devices, and the use of AI in diagnostics and personalized treatment._x000D_

    _x000D_

    #Download The Free Sample Report Here:#_x000D_

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24585&type=smp_x000D_

    _x000D_

    #Which Key Companies Are Shaping the Future of the Lateral Epicondylitis Treatment Market?#_x000D_

    Major companies operating in the lateral epicondylitis treatment market are Merck & Co. Inc., 3M Company, Mayo Foundation for Medical Education and Research (MFMER), Cleveland Clinic, Chugai Pharmaceutical, Johns Hopkins Medicine, MedStar Health, Cipla Inc., Enovis Corporation, OttoBock HealthCare, Ossur Corporate, Max Healthcare, Seikagaku Corporation, Texas Orthopedic Specialists, Johari Digital, Mediheal Group of Hospitals, Scandinavian Physiotherapy Center, Veritas Health LLC, Folsom Orthopaedics & Sports Medicine, ReLiva Physiotherapy & Rehab, Molecular Pharmacology Limited_x000D_

    _x000D_

    #Which Factors Are Driving Demand in the Lateral Epicondylitis Treatment Industry?#_x000D_

    The rise in sports and physical pursuits is anticipated to boost advancements in the market for lateral epicondylitis treatment. Sports and physical activities consist of planned or leisure physical exertions made to enhance physical health, sustain wellness, or partake in competitive or recreational endeavors. Due to the surge in awareness of the importance of health, more individuals are focusing on fitness to ward off diseases and boost physical and mental wellness. Lateral epicondylitis treatment aids those involved in sports and physical activities by restoring painless arm movement, enabling individuals to execute actions like gripping and swinging without uneasiness or limitation. As an example, in February 2024 according to the Sports and Fitness Industry Association (SFIA), a trade association based in the US, reported that 78.8% of Americans, equivalent to 242 million people, engaged in at least one physical activity in 2023, representing a 2.2% increase from the previous year. Thus, the expansion in sports and physical pursuits is propelling the advancement of the lateral epicondylitis treatment market._x000D_

    _x000D_

    #Request For A Customized Report:#_x000D_

    https://www.thebusinessresearchcompany.com/customise?id=24585&type=smp_x000D_

    _x000D_

    #How Is the Lateral Epicondylitis Treatment Market Segmented by Several Divisions?#_x000D_

    The lateral epicondylitis treatment market covered in this report is segmented –_x000D_

    _x000D_

    1) By Treatment Type: Non-Surgical Treatment, Surgical Treatment_x000D_

    2) By Age Group: Pediatric, Adult, Geriatric_x000D_

    3) By Application: Athlete, Other Applications_x000D_

    4) By End Use: Hospitals, Ambulatory Surgical Centers, Orthopedic Clinics, Homecare Settings, Other End Uses_x000D_

    _x000D_

    Subsegments:_x000D_

    1) By Non-Surgical Treatment: Physical Therapy, Pharmacological Therapy, Orthotic Devices, Injections_x000D_

    2) By Surgical Treatment: Open Surgery, Arthroscopic Surgery_x000D_

    _x000D_

    #What are the Emerging Market Trends Driving the Growth of the Lateral Epicondylitis Treatment Industry?#_x000D_

    Leading businesses in the lateral epicondylitis treatment marketplace are concentrating their efforts on creating novel solutions, for example plasma therapies, that aim to broaden the spectrum of treatment alternatives and deliver advanced, non-surgical methods of care to patients suffering from orthopedic issues. Plasma therapies are procedures that utilize specific components of blood plasma, most notably antibodies or growth factors, in order to manage various medical ailments and aid the body’s recovery processes. For instance, Tree Top Hospital (TTH), a Maldives-based, cutting-edge hospital, initiated treatments utilizing platelet-rich plasma (PRP) in December 2023 as an integral part of their progressive orthopedic care offerings. This revolutionary therapy uses the body’s inherent healing attributes to treat certain musculoskeletal issues, such as lateral epicondylitis (commonly known as tennis elbow), initial stage knee arthritis, and injuries related to sports tendons. By implementing PRP therapy, TTH is aiming to boost patient recovery via minimally invasive regenerative solutions backed by scientific evidence, thereby minimizing reliance on surgical procedures._x000D_

    _x000D_

    #Access The Full Report Here:#_x000D_

    https://www.thebusinessresearchcompany.com/report/lateral-epicondylitis-treatment-global-market-report_x000D_

    _x000D_

    #Which Regions Are Driving Growth in the Lateral Epicondylitis Treatment Market?#_x000D_

    North America was the largest region in the lateral epicondylitis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lateral epicondylitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

    _x000D_

    #Purchase The Full Report Today:#_x000D_

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24585_x000D_

    _x000D_

    #This Report Delivers Insight On: #_x000D_

    1. How big is the lateral epicondylitis treatment market, and how is it changing globally?_x000D_

    2. Who are the major companies in the lateral epicondylitis treatment market, and how are they performing?_x000D_

    3. What are the key opportunities and risks in the lateral epicondylitis treatment market right now?_x000D_

    4. Which products or customer segments are growing the most in the lateral epicondylitis treatment market?_x000D_

    5. What factors are helping or slowing down the growth of the lateral epicondylitis treatment market?_x000D_

    _x000D_

    #About The Business Research Company:#_x000D_

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

    _x000D_

    #Get in touch with us:#_x000D_

    The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

    Americas +1 3156230293_x000D_

    Asia +44 2071930708_x000D_

    Europe +44 2071930708_x000D_

    Email us at info@tbrc.info_x000D_

    _x000D_

    #Follow us on:#_x000D_

    _x000D_

    LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model